Daniel Levitt

2015

In 2015, Daniel Levitt earned a total compensation of $1.6M as Executive Vice President and Chief Medical Officer at CytRx, a 10% increase compared to previous year.

Compensation breakdown

Bonus$150,000
Option Awards$796,500
Salary$625,000
Total$1,571,500

Levitt received $796.5K in option awards, accounting for 51% of the total pay in 2015.

Levitt also received $150K in bonus and $625K in salary.

Rankings

In 2015, Daniel Levitt's compensation ranked 5,753rd out of 13,638 executives tracked by ExecPay. In other words, Levitt earned more than 57.8% of executives.

ClassificationRankingPercentile
All
5,753
out of 13,638
58th
Division
Manufacturing
2,145
out of 5,190
59th
Major group
Chemicals And Allied Products
772
out of 1,854
58th
Industry group
Drugs
613
out of 1,528
60th
Industry
Biological Products, Except Diagnostic Substances
104
out of 254
59th
Source: SEC filing on May 20, 2016.

Levitt's colleagues

We found four more compensation records of executives who worked with Daniel Levitt at CytRx in 2015.

2015

Steven Kriegsman

CytRx

Chief Executive Officer

2015

John Caloz

CytRx

Chief Financial Officer

2015

Benjamin Levin

CytRx

General Counsel

2015

Scott Wieland

CytRx

Senior Vice President – Drug Development

In-depth

You may also like